Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.

Although human lung adenocarcinoma has diverse histological subtypes, the correlation between histological subtypes and occurrence of the p53 gene mutation has been given less attention. We investigated 145 surgically resected lung adenocarcinomas to search for the incidence of p53 mutations and for record data on survival in each histological subtype, according to the new WHO criteria (1999). The frequency of p53 mutation in bronchioloalveolar carcinoma (BAC; 0% in 17 cases) and BAC with invasive growth component (BAC-invasive; 11% in 27 cases), which is conventionally categorized as the mixed subtype in WHO typing, were apparently significantly lower than in other types (non-BAC including acinar, papillary, solid, or mixed histology with these subtypes; 48% in 101 cases; P < 0.01). Multivariate analysis revealed that the histological subtype including BAC-invasive was a strong, independent, and significant prognostic factor (P < 0.03), as were tumor size and pathological stage (P < 0.001 and 0.002, respectively) for overall survival. However, the occurrence of p53 mutation itself was seen to be significant only in case of the univariate analysis. Therefore, histological subtyping may be a better prognostic indicator than is p53 mutation. These findings suggest that the WHO classification with the BAC and BAC-invasive from other histological subtypes may prove useful to predict the outcome for surgically treated patients with lung adenocarcinoma.

[1]  N. Müller,et al.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.

[2]  T. Sekiya,et al.  Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. , 1992, Cancer research.

[3]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[4]  J. Hayashi,et al.  p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. , 1999, Cancer research.

[5]  Y. Inayama,et al.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.

[6]  Y. Nishiwaki,et al.  Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. , 2000, Lung cancer.

[7]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[8]  I. Andrulis,et al.  p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. , 1998, Cancer research.

[9]  K. Nakanishi Alveolar epithelial hyperplasia and adenocarcinoma of the lung. , 1990, Archives of pathology & laboratory medicine.

[10]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[11]  R. Chiba,et al.  Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis , 1993, Cancer.

[12]  S. Jiang,et al.  Tumor extension and cell proliferation in adenocarcinomas of the lung. , 1999, The American journal of pathology.

[13]  Y. Shimosato,et al.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[14]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[15]  Y. Nishiwaki,et al.  Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. , 2000, The Annals of thoracic surgery.

[16]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.